Mandibular Mucormycosis: A Report of Four Cases and a Discussion on Their Management
Open Access
- 14 October 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (10) , e30301
Abstract
Mucormycosis of the mandible (MOM) is a rare fungal infection, and only 23 cases had been reported during the last 50 years worldwide, from seven different countries. Most of the cases were reported in India (n=8, 34%), followed by the United States (n=5, 22%). It is usually associated with an immunocompromised state and generally occurs after tooth extraction. Radiographically, it presents with the characteristic sign of osteomyelitis. Most of the previous case reports/series on MOM described successful outcomes with the resection of the involved segment. However, our experience in managing these cases was quite different and it was observed that resection is seldom required. It was seen that MOM rarely causes cortical perforation. One of the probable reasons is the thicker cortical bone and well-confined boundary of the mandible. Another reason could be the fulminating nature of the disease that leads it to rapidly spread in less resistant medullary bone before perforating cortical bone. During surgery, a clear line was seen separating necrotic medullary bone from healthy cortical bone. The thicker cortical bone of the mandible was found to be resistant to fungal invasion; however, the medullary bone was rapidly invaded. Therefore, the healthy cortical bone could be saved. The preservation of the cortical parts thus helps in maintaining the continuity of the bone. Surgical curettage of necrotic medullary bone is usually the optimal method to manage MOM affecting the mandibular body or ramus region.Keywords
This publication has 17 references indexed in Scilit:
- COVID-19 and mucormycosis superinfection: the perfect stormInfection, 2021
- COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?BMJ Case Reports, 2021
- COVID-19, An Eye Opening Pandemic - A Mini ReviewActa Scientific Dental Scienecs, 2021
- Sino-orbital mucormycosis in a COVID-19 patientInternational Journal of Surgery Case Reports, 2021
- Pharmacokinetics and Pharmacodynamics of PosaconazoleDrugs, 2020
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research ConsortiumThe Lancet Infectious Diseases, 2019
- Successful Mandibular Mucormycosis Treatment in the Severely Neutropenic PatientJournal of Oral and Maxillofacial Surgery, 2019
- The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reportsClinical Microbiology and Infection, 2019
- Therapy of MucormycosisJournal of Fungi, 2018
- Posaconazole liquid vs tablet formulation in lung transplant recipientsMycoses, 2017